HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NEPH

Nephros, Inc. (NASDAQ)

Healthcare — Medical Instruments & Supplies

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

None 2 analysts
$3.37
$-0.20 (-5.60%)
Target: $7.00 (107.7%)
Sign in to add NEPH to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$36.59M
P/E Ratio (TTM)48.14
Forward P/E33.70
EPS (TTM)$0.07
Dividend Yield-
Profit Margin4.06%
Revenue Growth6.90%
ROE7.76%
Debt/Equity9.05
Recommendation None
Analyst Target$7.00
Analysts2
Indexes NASDAQ

Technical Indicators

RSI (14)56.4
Beta1.50
SMA 20-
SMA 40-
52-Week High$6.42
52-Week Low$2.66
50-Day Avg$3.34
200-Day Avg$4.14
Avg Volume23.4K
Volume3.8K

Performance Analysis

NEUTRAL

NEPH presents a mixed picture with both positive and negative indicators.

~ Trading at 19% of its 52-week range.
+ RSI at 56.4 shows positive momentum.
- P/E of 48.1 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 6.9% year-over-year.
~ Wall Street consensus is "none" from 2 analysts.
+ Average analyst target of $7.00 implies 107.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:22 UTC

Back to Screener Export Report